Central South University Press Co., Ltd.

Hunan Er-Kang Pharmaceutical Co., Ltd. (stock code: 300267) was founded in October 2003 and listed on the Shenzhen Stock Exchange on September 27, 2011. The company is located in the scenic *Liuyang Economic and Technological Development Zone. Since its establishment, the company has been engaged in the research and development, production, and sales of pharmaceutical products, mainly including pharmaceutical excipients, active pharmaceutical ingredients, and novel antibiotics.
The company is one of the domestic professional pharmaceutical excipient manufacturers with the *most complete varieties and the *largest scale, and is one of the few domestic enterprises possessing registration approval documents for the novel penicillin antibiotic—sulbenicillin sodium API and finished drug.
Er-Kang Pharmaceutical is a formulator and promoter of domestic pharmaceutical excipient industry standards. Adhering to the business philosophy of "Professionalism achieves the future, quality creates brilliance," it achieves specialized production, serialized varieties, scientific application, and quality service. At the same time, with the mission of "everything for the safety of medicines," the company regards the quality and safety of pharmaceutical excipients and other products as its lifeblood. Leveraging its advantages in the field of pharmaceutical excipients, it strives to improve the quality level of pharmaceutical excipients, promote the construction of pharmaceutical excipient standards systems, actively develop pharmaceutical excipient products for various formulations, achieve variety scale and quality standardization, and strive to build the company into the * in China's pharmaceutical excipient industry.

Honors obtained since the company's listing:
August 2011: Won the "Top Ten Pharmaceutical Excipient Brands"
January 2012: Won Forbes: 2012 China's * Most Potential Entrepreneurial Board Listed Companies (7th place)
July 2012: Won the 2011 Golden Bull * Best Entrepreneurial Growth Company (2nd place)
August 2013: Won "China ChiNext Listed Companies Top 20 by Value" (8th place), "China ChiNext Listed Companies Top Ten Management Teams" (10th place); won the 2012 (6th) Pharmaceutical Industry "Top Ten National Brands" title
February 2014: Won two honorary titles: "2013 Changsha Top 30 Industrial Enterprises" and "2013 Enterprise with Tax and Profit Over 100 Million Yuan"